Who are Raphael Pharmaceutical Inc.'s main suppliers?

Raphael Pharmaceutical Inc. (RAPH) key suppliers include: RAMBAM, WOLC, ORANY, ORANY. View the full supplier network at chainsifter.com/chain/RAPH.

Who are Raphael Pharmaceutical Inc.'s major customers?

Raphael Pharmaceutical Inc. (RAPH) key customers include: Cornerstone Strategic Investment Fund, Inc.. View the full customer network at chainsifter.com/chain/RAPH.

What sector is Raphael Pharmaceutical Inc. in?

Raphael Pharmaceutical Inc. (RAPH) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

RAPH Supply Chain: Raphael Pharmaceutical Inc. Supplier List & 8 Relationships

4Suppliers

1Customers

3Debt Items

20Related Chains

Raphael Pharmaceutical Inc. Suppliers

Ticker	Name	Confidence	Evidence
RAMBAM	RAMBAM	92%	On July 17, 2019, we entered into a sponsored Research Agreement with Rambam, pursuant to which the Company agreed to fund a research project, to be performed by Rambam
WOLC	WOLC	92%	Wolc will be the exclusive supplier of any approved pharmaceutical drug products of the Company in Israel.
ORANY	ORANY	72%	ct to the receipt of regulatory approval to commercialize our pharmaceutical product candidates, our goal is to distribute our approved formulas to good manufacturing practice, or GMP, approved medic…
ORANY	ORANY	72%	Reciprocal relationship from ORANY graph: Reciprocal relationship from RAPH graph: Reciprocal relationship from ORANY graph: Reciprocal relationship from RAPH graph: ct to the receipt of regulatory a…

Raphael Pharmaceutical Inc. Customers

Ticker	Name	Confidence	Evidence
CLM	Cornerstone Strategic Investment Fund, Inc.	80%	Reciprocal relationship from CLM graph: Reciprocal relationship from RAPH graph: Reciprocal relationship from CLM graph: Alias reverse search [Cornerstone]: RAPH 10-K (2026-03-31) mentions 'Cornersto…

Raphael Pharmaceutical Inc. Debt Obligations

Instrument	Description	Confidence	Evidence
RAPH-DEBT-12050	Xbrl Convertible	90%	xbrl convertible detail from xbrl 2025-12-31.
RAPH-DEBT-12049	Warrants outstanding: 1000000	90%	xbrl warrant detail from xbrl 2025-12-31.
RAPH-DEBT	Debt stack $37,000	90%	Market cache reports total debt of $37,000.

Raphael Pharmaceutical Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Raphael Pharmaceutical Inc..

Raphael Pharmaceutical Inc. Ownership

No ownership data on recordNo major institutional ownership relationships found in our database for Raphael Pharmaceutical Inc..

Raphael Pharmaceutical Inc. Extended Supply Chain Network

Ticker	Name	Chain Index	Hops	Relationship Types
ORANY	ORANGE	100.00	1	['supplier']
AMZE	Amaze Holdings, Inc.	50.00	2
CNOB	ConnectOne Bancorp, Inc.	50.00	2
CPRX	Catalyst Pharmaceuticals, Inc.	50.00	2
AYTU	Aytu BioPharma, Inc.	50.00	2
D	Dominion Energy, Inc.	50.00	2
DARE	Daré Bioscience, Inc.	50.00	2
CYCN	Cyclerion Therapeutics, Inc.	50.00	2
CANF	Can-Fite BioPharma Ltd.	50.00	2
DFTX	Definium Therapeutics, Inc.	50.00	2
CHUC	Charlie's Holdings, Inc.	50.00	2
CLNE	Clean Energy Fuels Corp.	50.00	2
FENC	Fennec Pharmaceuticals Inc.	50.00	2
EQR	Equity Residential	50.00	2
BLTE	Belite Bio, Inc	50.00	2
DWTX	Dogwood Therapeutics, Inc.	50.00	2
ESS	Essex Property Trust, Inc.	50.00	2
ED	Consolidated Edison, Inc.	50.00	2
SCNX	Scienture Holdings, Inc.	50.00	2
AUMN	Golden Minerals Company	50.00	2

Raphael Pharmaceutical Inc. Supply Chain